Novavax Inc Cash Flow Reinvestment Rate
Novavax Inc cash flow reinvestment rate. Novavax Inc (NVAX) has a Cash Flow Reinvestment Rate of 1.29x as of September 2025, reinvesting $138.55 Million (capex $2.02 Million plus investments $-136.53 Million) from operating cash flow of $107.80 Million. Explore NVAX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Novavax Inc (2021–2021)
Cash flow reinvestment rate of Novavax Inc from 2021 to 2021. Historical reinvestment intensity for Novavax Inc across 1 annual periods. Explore NVAX capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Novavax Inc Cash Flow Reinvestment Rate by Year (2021–2021)
Novavax Inc cash flow reinvestment rate by year from 2021 to 2021. Year-by-year capital reinvestment analysis for Novavax Inc. For the full cash flow conversion analysis, see NVAX cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.67x | $215.13 Million | $322.95 Million | $57.49 Million | — |